Skip to main content
. 2011 Mar;4(2):228–239. doi: 10.1242/dmm.006130

Fig. 7.

Fig. 7.

Blocked M-CSF signal transduction in induced SHP-2-deficient mice. (A) Bone marrow cells from a ptpn11fl/fl ert2-cre mouse and a littermate ptpn11fl/fl mouse (both treated with tamoxifen 10 days beforehand at 7 weeks of age) were cultured in wells of a 24-well plate (1×106 cells/well) in the presence of M-CSF. After 5 days, macrophages in wells were harvested and counted. Depicted is the mean number of macrophages ± 1 s.e.m. (n=4). Results are representative of four repeat experiments. Statistical significance was determined by two sample Student’s t-test. **P<0.005. (B) Western blots showing expression of SHP-2 in bone marrow cells (freshly isolated or after culture in M-CSF for 5 days) from a ptpn11fl/fl ert2-cre mouse and a littermate ptpn11fl/fl mouse (both treated with tamoxifen 3 weeks beforehand at 6 weeks of age). NS, non-specific band. Blots were stripped and reprobed with an anti-GAPDH antibody to verify equivalent protein loading. Similar results were obtained in five independent experiments. (C) Lineage-negative bone marrow cells from a ptpn11fl/fl ert2-cre mouse and a littermate ptpn11fl/fl mouse (both treated with tamoxifen 10 days beforehand at 6 weeks of age) were stimulated with M-CSF for the indicated times (in minutes). Activation of AKT was determined by western blotting of whole-cell lysates using a phospho-specific anti-AKT antibody. Blots were reprobed with an anti-AKT antibody to verify equal loading. Similar results were obtained in three repeat experiments.